NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Short Interest Up 58.3% in February

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 1,900 shares, an increase of 58.3% from the February 13th total of 1,200 shares. Based on an average daily volume of 24,900 shares, the short-interest ratio is presently 0.1 days.

NRx Pharmaceuticals Trading Down 33.4 %

NRXPW traded down $0.04 during trading on Monday, hitting $0.08. The company had a trading volume of 19,677 shares, compared to its average volume of 35,105. NRx Pharmaceuticals has a one year low of $0.04 and a one year high of $0.50. The firm’s 50-day moving average price is $0.18 and its 200 day moving average price is $0.11.

About NRx Pharmaceuticals

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.